Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new page revision tag, Revision: v3.6.6, was added. Several related-topic items (Ovarian cancer, MedlinePlus Genetics) and the 'related topics' header were removed.
    Difference
    0.1%
    Check dated 2026-09-01T21:53:48.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study's identifiers section now includes an NIH grant/contract entry (2017). This indicates funding associated with the trial.
    Difference
    0.0%
    Check dated 2026-08-25T22:27:23.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the page's topics. Updated the site revision from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T15:34:37.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Ovarian cancer and related topics: MedlinePlus Genetics were removed from the page. This changes how the study is categorized and cross-referenced with ovarian cancer and genetics resources.
    Difference
    0.1%
    Check dated 2026-08-04T09:58:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing Revision: v3.6.3, signaling a minor site version update. This change does not modify study details or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-28T05:47:22.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added related topics entries to the page, introducing Ovarian cancer as a topic and a MedlinePlus Genetics link to related topics. These entries expand navigational context for readers exploring the study page.
    Difference
    0.1%
    Check dated 2026-07-13T20:03:55.000Z thumbnail image

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.